发明授权
US5137912A Chelerythrine inhibits platelet aggregation--a potential
anti-aggregation drug
失效
白藜芦醇抑制血小板聚集 - 潜在的抗凝聚药物
- 专利标题： Chelerythrine inhibits platelet aggregation--a potential anti-aggregation drug
- 专利标题（中）： 白藜芦醇抑制血小板聚集 - 潜在的抗凝聚药物
-
申请号： US646373申请日： 1991-01-28
-
公开(公告)号： US5137912A公开(公告)日： 1992-08-11
- 发明人: Che-Ming Teng , Ih-Sheng Chen , Tur-Fu Huang , Feng-Nien Ko , Shwu-Jen Wu , Shwu-Jen Wu
- 申请人： Che-Ming Teng , Ih-Sheng Chen , Tur-Fu Huang , Feng-Nien Ko , Shwu-Jen Wu , Shwu-Jen Wu
- 申请人地址： TWX Taipei
- 专利权人： National Science Council of Republic of China
- 当前专利权人： National Science Council of Republic of China
- 当前专利权人地址： TWX Taipei
- 主分类号： A61K31/44
- IPC分类号： A61K31/44
摘要：
This invention refer to chelerythrine, a considerably effective drug in the prevention and therapy of the thrombosis, which is a quaternary amine derivative and a major component of the organic solvent soluble extract of Zanthoxylum simulans. The effects of chelerythrine on the thromboembolism and the constriction of the blood vessel are also examined.
公开/授权文献
信息查询
